177 related articles for article (PubMed ID: 19016750)
1. Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity.
Hagiwara S; Murakumo Y; Sato T; Shigetomi T; Mitsudo K; Tohnai I; Ueda M; Takahashi M
Cancer Sci; 2008 Oct; 99(10):1916-23. PubMed ID: 19016750
[TBL] [Abstract][Full Text] [Related]
2. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
Zhou S; da Silva SD; Siegel PM; Philip A
Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD109 in oral squamous cell carcinoma and its clinical significance.
Chen H; Junji Xu ; Ge R; Liu C
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):145-149. PubMed ID: 38814222
[TBL] [Abstract][Full Text] [Related]
4. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
5. CD109 and squamous cell carcinoma.
Qi R; Dong F; Liu Q; Murakumo Y; Liu J
J Transl Med; 2018 Apr; 16(1):88. PubMed ID: 29625613
[TBL] [Abstract][Full Text] [Related]
6. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
[TBL] [Abstract][Full Text] [Related]
7. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
[TBL] [Abstract][Full Text] [Related]
8. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.
Hagikura M; Murakumo Y; Hasegawa M; Jijiwa M; Hagiwara S; Mii S; Hagikura S; Matsukawa Y; Yoshino Y; Hattori R; Wakai K; Nakamura S; Gotoh M; Takahashi M
Pathol Int; 2010 Nov; 60(11):735-43. PubMed ID: 20946523
[TBL] [Abstract][Full Text] [Related]
9. Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.
Hagiwara S; Murakumo Y; Mii S; Shigetomi T; Yamamoto N; Furue H; Ueda M; Takahashi M
Oncogene; 2010 Apr; 29(15):2181-91. PubMed ID: 20101215
[TBL] [Abstract][Full Text] [Related]
10. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
[TBL] [Abstract][Full Text] [Related]
11. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
12. CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.
Zhang JM; Murakumo Y; Hagiwara S; Jiang P; Mii S; Kalyoncu E; Saito S; Suzuki C; Sakurai Y; Numata Y; Yamamoto T; Takahashi M
Biochem Biophys Res Commun; 2015 Apr; 459(2):252-258. PubMed ID: 25724945
[TBL] [Abstract][Full Text] [Related]
13. CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder.
Dong F; Lu C; Chen X; Guo Y; Liu J
Diagn Pathol; 2015 Aug; 10():137. PubMed ID: 26249215
[TBL] [Abstract][Full Text] [Related]
14. The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma.
Yoon HJ; Hong JS; Shin WJ; Lee YJ; Hong KO; Lee JI; Hong SP; Hong SD
Oral Oncol; 2011 Nov; 47(11):1023-31. PubMed ID: 21824804
[TBL] [Abstract][Full Text] [Related]
15. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
16. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
17. Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis.
Liu XX; Feng AP; He YM; Li Y; Wu Y; Lian X; Hu F; Li JW; Tu YT; Chen SJ
J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):132-136. PubMed ID: 26838754
[TBL] [Abstract][Full Text] [Related]
18. Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling.
Mori N; Esaki N; Shimoyama Y; Shiraki Y; Asai N; Sakai T; Nishida Y; Takahashi M; Enomoto A; Mii S
Pathol Res Pract; 2023 May; 245():154443. PubMed ID: 37030166
[TBL] [Abstract][Full Text] [Related]
19. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
Man XY; Finnson KW; Baron M; Philip A
Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical distribution and morphometric analysis of aquaporin-3 in oral squamous cell carcinoma.
Matsuo K; Kawano K
Int J Oral Maxillofac Surg; 2014 Jan; 43(1):13-21. PubMed ID: 23830572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]